Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion type Assertion NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_head.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion wasGeneratedBy ECO_0000203 NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion wasDerivedFrom befree-2016 NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion SIO_000772 19920204 NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion evidence source_evidence_literature NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.
- NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.